Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chas Bountra

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Angewandte Chemie (International Ed. in English)|November 16, 2018
Design, Synthesis and Characterization of Covalent KDM5 InhibitorsSaleta Vazquez-Rodriguez, Miranda Wright, Catherine M Rogers, et al.
Biomedical Reports|March 23, 2018
Therapeutics discovery: From bench to first in-human trialsEnsaf M Al-Hujaily, Tanvir Khatlani, Zeyad Alehaideb, et al.
Epigenetics & Chromatin|March 8, 2017
Assessing histone demethylase inhibitors in cells: lessons learnedStephanie B Hatch, Clarence Yapp, Raquel C Montenegro, et al.
Cell Chemical Biology|March 7, 2017
Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma CellsAnthony Tumber, Andrea Nuzzi, Edward S Hookway, et al.
Nature|October 4, 2014
Kruidenier et al. replyLaurens Kruidenier, Chun-wa Chung, Zhongjun Cheng, et al.
Scientific Reports|July 24, 2021
Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasiaMichael A Kiebish, Poornima Tekumalla, Shobha Ravipaty, et al.
Nature Genetics|June 30, 2019
A genetics-led approach defines the drug target landscape of 30 immune-related traitsHai Fang, , Hans De Wolf, et al.
Nature|July 31, 2012
A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage responseLaurens Kruidenier, Chun-wa Chung, Zhongjun Cheng, et al.
Journal of Medicinal Chemistry|September 25, 2019
A Chemical Probe for Tudor Domain Protein Spindlin1 to Investigate Chromatin FunctionVincent Fagan, Catrine Johansson, Carina Gileadi, et al.
Bioorganic & Medicinal Chemistry Letters|June 13, 2009
Identification of [4-[4-(methylsulfonyl)phenyl]-6-(trifluoromethyl)-2-pyrimidinyl] amines and ethers as potent and selective cyclooxygenase-2 inhibitorsMartin E Swarbrick, Paul J Beswick, Robert J Gleave, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Angewandte Chemie (International Ed. in English)|November 16, 2018
Design, Synthesis and Characterization of Covalent KDM5 InhibitorsSaleta Vazquez-Rodriguez, Miranda Wright, Catherine M Rogers, et al.
Biomedical Reports|March 23, 2018
Therapeutics discovery: From bench to first in-human trialsEnsaf M Al-Hujaily, Tanvir Khatlani, Zeyad Alehaideb, et al.
Epigenetics & Chromatin|March 8, 2017
Assessing histone demethylase inhibitors in cells: lessons learnedStephanie B Hatch, Clarence Yapp, Raquel C Montenegro, et al.
Cell Chemical Biology|March 7, 2017
Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma CellsAnthony Tumber, Andrea Nuzzi, Edward S Hookway, et al.
Nature|October 4, 2014
Kruidenier et al. replyLaurens Kruidenier, Chun-wa Chung, Zhongjun Cheng, et al.
Scientific Reports|July 24, 2021
Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasiaMichael A Kiebish, Poornima Tekumalla, Shobha Ravipaty, et al.
Nature Genetics|June 30, 2019
A genetics-led approach defines the drug target landscape of 30 immune-related traitsHai Fang, , Hans De Wolf, et al.
Nature|July 31, 2012
A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage responseLaurens Kruidenier, Chun-wa Chung, Zhongjun Cheng, et al.
Journal of Medicinal Chemistry|September 25, 2019
A Chemical Probe for Tudor Domain Protein Spindlin1 to Investigate Chromatin FunctionVincent Fagan, Catrine Johansson, Carina Gileadi, et al.
Bioorganic & Medicinal Chemistry Letters|June 13, 2009
Identification of [4-[4-(methylsulfonyl)phenyl]-6-(trifluoromethyl)-2-pyrimidinyl] amines and ethers as potent and selective cyclooxygenase-2 inhibitorsMartin E Swarbrick, Paul J Beswick, Robert J Gleave, et al.
Pageof 8